ABBV-744 clinical trial phase 2 data Things To Know Before You Buy
These side effects were being notably milder compared to an inhibitor of equally bromodomains. An in depth molecular Evaluation also discovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen Taylor88 These preclinical studies deliver paradigms for long term clinical trials in AML, and t